Table 1.
Baseline characteristics of the 86 women followed until delivery
Iodine-supplemented group | Control group | |
Subjects | 32 | 54 |
Age, years | 28 (21–37) | 27 (18–39) |
BMI, kg/m2 | 21.9 (17.9–30.8) | 22.3 (16.0–39.5) |
Term at first visit (WA) | 10.0 (7–12) | 10.0 (7.0–12) |
Parity | 0 (0–2) | 0 (0–4) |
Smokers at the visit, % | 25.8 | 27.8 |
Thyroid volume, ml | 10.1 (5.3–16.7) | 9.5 (5.4–18) |
Initial UIE, µg/l | 111 (28–399) | 103 (14–355) |
Initial FT4, pmol/l | 14.1 (12–17.2) | 14.8 (12–18.5) |
Initial TSH, mIU/l | 1.2 (0.1–2.4) | 1.2 (0.2–2.4) |
FT3, pmol/l | 5.1 (3.8–6.7) | 5.0 (4.1–6.2) |
Tg, µg/l | 17 (2.4–45.1) | 17.5 (1.3–84.1) |
TT4, nmol/l | 116.7 (73.3–162) | 111.2 (71.5–157.3) |
TBG, mg/l | 27.4 (19.5–50) | 26.3 (12.8–48.9) |
Data are presented as median and range. No differences were observed between the 2 groups.